UK-396082

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameUK-396082
Drug Alias NameUK-396082
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCarboxypeptidase B2 isoform A inhibitors
TargetsCarboxypeptidase B2 isoform A
Therapy Area/IndicationsThrombosisPulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsThrombosisPulmonary Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A